Background Pembrolizumab monotherapy showed durable antitumour activity and manageable
safety in patients with metastatic triple-negative breast cancer. We aimed to examine …

Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line
therapy for HER2-positive metastatic breast cancer, based on results from the phase III …

Introduction Knowing the important factors influencing sexual function and body image might
facilitate the recovery process of breast cancer survivors. Surgery type, relationship quality, …

Mast cells (MCs) are a part of the innate immune system. The MC functions toward cancer
are partially based on the release of chymase and tryptase. However, the MC effect on breast …

Cardiovascular disease is the major cause of morbidity and mortality in breast cancer
survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long-term …

Dendritic cells (DCs) constitute a part of the tumour microenvironment, but we are still far from
understanding their complex role in immune response to the tumour. This study aimed to …

Objective DCVAC/OvCa is an active cellular immunotherapy designed to stimulate an
immune response against ovarian cancer. We explored the safety and efficacy of DCVAC/OvCa …

Objective Analysis of the relationship between the body self (BS) and the sense of coherence
(SOC) in women after breast surgery due to cancer in comparison with a control group. …

Aim. The aim of the study was to verify the following hypotheses:(1) Do women who have
undergone surgical treatment for breast cancer differ from healthy women in the way they …

Background: Anthracycline‑induced cardiotoxicity (AIC) remains the main long‑term
irreversible side effect in malignancy survivors. Cardiotoxicity prevention is one of the most …